Strata Critical Medical, Inc. Class A Common Stock
SRTA
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
Last trade$5.27
Day change-$0.15 (-2.77%)
Day range$5.06 – $5.65
Volume517,408
Market cap$484M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$484.11M
Price / earnings
—
Price / book
1.75×
Price / sales
1.72×
EV / sales
1.6×
EV / EBITDA
137.01×
Profitability
Earnings per share
-$0.28
Return on assets
-7.54%
Return on equity
-8.98%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
2.77×
Quick ratio
2.77×
Cash ratio
0.78×
Cash flow
Price / cash flow
45.15×
Price / free cash flow
600.64×
Free cash flow
$806K
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SRTA, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Revenue
$74.08M
$72.51M
$67.38M
$66.79M
$49.3M
Cost of revenue
$57.26M
$57.29M
$53.27M
$55.12M
$38.64M
Gross profit
$16.82M
$15.22M
$14.12M
$11.67M
$10.65M
Selling, general and administrative
$15.14M
$14M
$15.61M
$16.83M
$15.91M
Research and development
$0
$0
$0
-$1.35M
$0
Total operating expenses
$20.65M
$20.62M
$17.09M
$18.08M
$16.28M
Operating income
-$3.83M
-$5.41M
-$2.97M
-$6.41M
-$5.62M
Interest expense
$146K
$331K
$473K
$0
$1.13M
Income before taxes
-$7.62M
-$10.52M
$2.4M
-$5.39M
-$9.66M
Income taxes
$0
$0
$0
$0
$0
Net income
-$7.62M
-$10.52M
$2.15M
-$8.83M
$57.42M
Net income attributable to common shareholders
-$7.62M
-$10.52M
$2.15M
-$8.83M
$57.42M
EBITDA
$3.48M
$3.11M
$86K
-$3.4M
-$3.92M
Basic earnings per share
-$0.09
-$0.12
$0.03
-$0.10
$0.70
Diluted earnings per share
-$0.09
-$0.12
$0.03
-$0.10
$0.70
Recent news
Company coverage with links to the original publishers.
BrightSpring Health Services reported Q3 2026 earnings of $0.54 per share, beating consensus estimates of $0.49, with revenues of $4.21 billion exceeding expectations by 9.17%. The company has outperformed the market by 60.8% year-to-date compared to the S&P 500's 12.8% gain. However, the stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
Alignment Healthcare (ALHC) reported a quarterly loss of $0.04 per share, matching consensus estimates, with revenues of $1.36 billion exceeding expectations by 3.63%. However, the stock has declined 58.6% year-to-date, significantly underperforming the S&P 500's 13.1% gain. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, with the Medical Services industry ranking in the bottom 40% of sectors.
Strata Critical Medical (Nasdaq: SRTA) announced it will release Q2 2026 financial results on August 4, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Melissa Tomkiel and Will Heyburn. The company is a time-critical logistics and medical services provider specializing in organ transplant services, air/ground logistics, and surgical recovery operations.
Strata Critical Medical (Nasdaq: SRTA) announced it will release fourth quarter 2025 financial results on March 3, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Will Heyburn and Melissa Tomkiel. The company is a time-critical logistics and medical services provider specializing in organ transplant networks and surgical services.
Strata Critical Medical has appointed Will Cook, President and CEO of Vail Health, to its Board of Directors. Cook brings extensive healthcare leadership experience from roles at University of Colorado Hospital, UPMC, and Johns Hopkins Health System.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.